Needles Market Size, Share & Trends Analysis Report By Product Type (Safety Needles, Conventional Needles, Pen Needles, Suture Needles, Blood Collection Needles, Spinal Needles, Others), By Application (Drug Delivery, Vaccination, Blood Collection, Surgical Procedures, Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, Diagnostic Centers, Home Healthcare Settings, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Needles Market Size

The global needles market size was valued at USD 7.79 billion in 2025 and is projected to grow from USD 8.29 billion in 2026 to USD 13.61 billion by 2034, registering a CAGR of 6.4% during the forecast period from 2026 to 2034. North America dominated the needles market with a market share of 36.2% in 2025.

The global needles market is experiencing steady growth due to the increasing prevalence of chronic diseases, rising demand for vaccinations, and the expansion of healthcare infrastructure globally. An ageing population and increasing incidences of diabetes, cancer, and cardiovascular conditions have accelerated the use of needles in diagnostic and treatment procedures. Technological advancements, such as safety-engineered and retractable needles, also contribute to market expansion by reducing the risk of needlestick injuries.

Furthermore, the growth in minimally invasive procedures has increased the adoption of fine needles and biopsy needles. Trends such as self-administration of drugs, especially insulin, are encouraging the use of pen needles and intravenous injection needles. The World Health Organisation's emphasis on global immunisation programs and national health campaigns, especially in developing regions, is increasing the frequency of injections administered, thereby expanding the market. Additionally, sustainability initiatives and developing eco-friendly needle materials are gaining traction as manufacturers respond to environmental concerns and healthcare waste regulations.

Needles Market Size

Download a Free Sample To learn more about this report.

Product Type Insights

Safety needles are leading the market due to their ability to prevent needlestick injuries, which are a significant concern for healthcare workers. The increasing awareness about occupational hazards and stringent regulations mandating the use of safety-engineered devices has propelled the adoption of safety needles. Safety needles have protective mechanisms such as sheaths or retractable systems, significantly reducing exposure risks. Major healthcare providers increasingly incorporate these devices into routine care to comply with infection control standards. Technological advancements such as auto-disable and passive safety needles also contribute to ease of use and higher compliance, especially in vaccination drives.

Needles Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The drug delivery segment dominates the application category, attributed to the rising prevalence of chronic diseases such as diabetes and cancer, which require regular administration of medications via injections. The convenience and efficiency of needle-based drug delivery systems have made them a preferred choice in healthcare settings. Furthermore, advancements in biologics and the increasing number of injectable drugs in the pipeline are expected to boost this segment's growth. Prefilled syringes and pen injectors have driven innovation in this segment, enhancing patient adherence and convenience. This segment is expected to maintain its lead as self-administration grows in home settings, particularly in developed economies.

End User Insights

Hospitals and clinics are the primary end-users of needles, accounting for the largest market share. The high patient footfall, availability of skilled healthcare professionals, and the presence of advanced infrastructure contribute to the dominance of this segment. Additionally, the increasing number of surgical procedures and the growing demand for minimally invasive treatments in hospital settings further drive the usage of various types of needles. Hospitals also maintain high infection control standards, necessitating frequent procurement of sterile and safety-compliant needles. Government-funded health schemes and insurance coverage for hospital-based treatments in regions such as Europe and Asia-Pacific further support the segment’s growth.

Needles Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America holds the largest share of the global needles market, driven by advanced healthcare infrastructure, high healthcare expenditure, and the presence of major market players. The region's growth is further supported by the increasing prevalence of chronic diseases and the rising demand for safety-engineered devices. Moreover, the strong presence of leading manufacturers such as Becton, Dickinson and Company and Cardinal Health, and significant R&D investments ensure continuous innovation in needle technologies. The region also benefits from the growing demand for home healthcare and self-injection devices, particularly for diabetes and autoimmune conditions. Additionally, robust regulatory frameworks from bodies such as the FDA ensure strict compliance with safety standards, further boosting adoption.

U.s. Needles Market Trends

  • The U.S. is the largest market for needles globally, owing to its advanced healthcare system, high prevalence of chronic diseases such as diabetes and cardiovascular conditions, and the presence of key market players. The country has a high adoption rate of innovative healthcare technologies, including safety-engineered needles that help prevent needlestick injuries. Regulatory agencies like the FDA have stringent guidelines promoting safety and efficacy, driving continuous product upgrades. Expanding immunization programs, including seasonal flu shots and COVID-19 booster campaigns, fuel demand across clinical and non-clinical settings.
  • Canada's needles industry is growing steadily, supported by a well-established universal healthcare system and government initiatives emphasizing patient safety and infection control. The country has witnessed increasing demand for safety-engineered devices in both hospital and home care settings, driven by rising chronic illness rates such as diabetes and cancer. The government’s regulatory oversight through Health Canada ensures that high-quality and safe products dominate the market. Additionally, Canadian hospitals invest in medical automation and training, creating demand for more ergonomic, easy-to-use needle designs.
North America Needles Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Needles Market Trends

Asia-Pacific is the fastest-growing region in the global needles market, driven by large populations, increasing healthcare access, and the rising incidence of chronic diseases. Countries like China and India are witnessing expanding healthcare infrastructures, higher health spending, and greater government focus on immunization programs. The rapid rise in diabetes cases across the region also boosts needle demand. Additionally, the area is experiencing a surge in minimally invasive surgical procedures, necessitating a higher volume of fine surgical needles. Medical tourism in countries like Thailand and India is further accelerating demand for high-quality medical supplies. Collaborations between domestic manufacturers and international players facilitate technology transfers, enhancing the quality and safety of needle products. With supportive government policies and rapid economic development, Asia-Pacific is poised to be the powerhouse of market growth.

  • China’s needles market is expanding rapidly due to a vast population, growing healthcare expenditure, and significant public health initiatives. The government's commitment to improving healthcare access through the “Healthy China 2030” plan has led to a surge in hospital construction and the upgrading of primary care services. Rising chronic disease rates, particularly diabetes and hypertension, are further boosting the market for therapeutic needles and self-injection devices. The Chinese government is also implementing stricter regulatory oversight to enhance safety and reduce cross-contamination, creating opportunities for higher-grade, safety-engineered needles in rural and urban healthcare settings.
  • India is emerging as one of the most promising markets for needles, thanks to its growing healthcare sector, expanding population, and increasing awareness of infection control. Government-led immunization programs, such as Mission Indradhanush and the Universal Immunization Programme (UIP), are major drivers of demand. The rapid rise in lifestyle-related diseases like diabetes has created a growing need for daily-use injection devices, especially in urban centers. Regulatory reforms under the Central Drugs Standard Control Organization (CDSCO) are gradually aligning Indian standards with global benchmarks, improving product quality and boosting international confidence in Indian-made medical devices.

Europe Needles Market Trends

Europe is a significant market for needles, backed by stringent safety regulations, government healthcare initiatives, and growing chronic disease burdens. Countries such as Germany, France, and the U.K. have robust public health systems that facilitate high-volume procurement of medical supplies, including needles. The European Union’s Sharps Directive (2010/32/EU) mandates the use of safety-engineered needles across healthcare settings, which has significantly driven safety needle adoption. Rising healthcare expenditure and the emphasis on early diagnosis and treatment support using diagnostic and surgical needles. The focus on cross-border healthcare coordination and public-private partnerships further supports the efficient supply and regulation of high-quality needle products. With well-established healthcare policies, strong pharmaceutical manufacturing capacity, and a growing focus on patient safety, Europe remains a strong contributor to global market expansion.

  • The UK has witnessed significant growth in the market, largely driven by the National Health Service's (NHS) initiatives to enhance patient safety and reduce needlestick injuries. The country has established procurement standards with a strong public healthcare system that favors safety-engineered and innovative needle technologies. A growing geriatric population and a steady rise in chronic diseases like arthritis and multiple sclerosis are increasing the requirement for injectable therapies. The emphasis on surgical efficiency and infection control within NHS hospitals also promotes the use of prefilled syringes and disposable needles.
  • Germany is a key market in Europe for needles, characterized by a highly organized and well-funded healthcare system. The country emphasizes safety in medical practices, adhering to EU regulations requiring the use of safety-engineered needles in healthcare environments. Germany has a large aging population, leading to an increase in chronic diseases and thereby boosting the demand for injectable therapies. Hospitals and outpatient clinics are increasingly adopting needle devices that reduce the risk of transmission of bloodborne pathogens. Germany's strong medical device manufacturing base also ensures a robust supply of high-quality needle products for domestic use and export.

Company Market Share

The global market for needles is highly competitive, with several key players focusing on product innovation, strategic partnerships, and mergers & acquisitions to strengthen their market position. Companies are investing in research and development to introduce advanced needles with enhanced safety features and improved patient comfort. The market is characterized by established players and emerging companies striving to capture a significant share.

Becton, Dickinson and Company (BD): Becton, Dickinson and Company (BD) is a leading player in the needles market, offering a comprehensive range of products, including safety-engineered needles, pen needles, and conventional needles. The company's strong focus on innovation and commitment to enhancing healthcare worker safety have solidified its market position. BD's extensive distribution network and strategic collaborations have enabled it to maintain a global market share.

List of Key and Emerging Players in Needles Market

Becton, Dickinson and Company
Johnson & Johnson (Ethicon)
Stryker Corporation
Medtronic PLC
Novo Nordisk A/S
Boston Scientific Corporation
Smiths Medical
Terumo Corporation
Nipro Corporation
Vita Needle Company
Hilgenberg GmbH
Unimed S.A.
Groz-Beckert KG
Teleflex Incorporated

Key Industry Developments

June 2026
Becton, Dickinson and Company (BD) expanded its needle and injection device portfolio by advancing safety-engineered needle technologies and drug delivery solutions. The company focused on improving healthcare worker safety, injection accuracy, and patient care efficiency.
May 2026
Terumo expanded its medical device portfolio by advancing hypodermic needles, specialty needles, and injection technologies. The initiatives focused on improving precision, reliability, and usability across clinical and healthcare applications.
April 2026
Nipro expanded its medical consumables portfolio through advancements in needle manufacturing technologies and injection-related products. The company focused on improving product quality, safety features, and accessibility for healthcare providers.
January 2026
B. Braun expanded its injection and infusion therapy portfolio by advancing needle technologies and medication delivery solutions. The company focused on enhancing safety, performance, and efficiency in healthcare procedures.

Report Scope

Segmentation

By Product Type 7
  • Safety Needles
  • Conventional Needles
  • Pen Needles
  • Suture Needles
  • Blood Collection Needles
  • Spinal Needles
  • Others
By Application 5
  • Drug Delivery
  • Vaccination
  • Blood Collection
  • Surgical Procedures
  • Others
By End-User 5
  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Home Healthcare Settings
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Becton, Dickinson and Company · Johnson & Johnson (Ethicon) · Stryker Corporation · Medtronic PLC · Novo Nordisk A/S
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The needles market size is valued at USD 8.29 Billion in 2026 and is projected to reach USD 13.61 Billion by 2034, at a CAGR of 6.4% during the forecast period 2026-2034.

North America dominated the market with a share of 36.2% in 2025.

The leading players in this market are Becton, Dickinson and Company, Johnson & Johnson, Stryker Corporation, Medtronic PLC.

The needles market is projected to grow at a CAGR of 6.4% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now

We are featured on: